A Study of Patients With Chronic Disease
Reason given: Sponsor decision to terminate study
Key facts
- Where
- Ann Arbor, Clearwater, Colorado Springs, Louisville, and New Bern, United StatesSee the 5 sites
Where in United States
- University of Michigan Allergy Specialty Clinic & Food AllergyAnn Arbor, United StatesNo longer taking part
- St Francis Medical InstituteClearwater, United StatesNo longer taking part
- Asthma and Allergy Associates, PCColorado Springs, United StatesNo longer taking part
- Family Allergy & Asthma Research InstitutionLouisville, United StatesNo longer taking part
- Coastal Carolina Healthcare, P.A.New Bern, United StatesNo longer taking part
Trial details
- Who runs it
- Target PharmaSolutions, Inc.
- Trial code
- NCT04263727
- Record updated
- 3 April 2025
- Original description
TARGET-RWE is a 10-year, international, longitudinal, observational study of patients with chronic disease designed to specifically address important clinical questions that remain incompletely answered from registration trials. The protocol will follow a master protocol design in which a shared study infrastructure supports progressive development of the registry across the spectrum of chronic diseases.Read full original descriptionShow less
A Longitudinal Observational Study of Patients With Chronic Disease
TARGET-RWE is a 10-year, international, longitudinal, observational study of patients with chronic disease designed to specifically address important clinical questions that remain incompletely answered from registration trials. The protocol will follow a master protocol design in which a shared study infrastructure supports progressive development of the registry across the spectrum of chronic diseases.
Inclusion: Adults and children being managed or treated for a chronic disease under study. Diagnosis is based on the clinical judgement of the care provider; Patient is anticipated to have continued management of their chronic disease at the participating site.
Exclusion: Inability to provide informed assent/consent.